Absstract
Diabetes mellitus occurs in approximately 18% of persons between the ages of 65 and 75 and in up to 40% of persons over age 80 years.
Elevated serum glucose levels associated with diabetes mellitus alter host immune responses, resulting in predisposition to infections.
The cumulative effect of age-related immune senescence, superimposed on this enhanced risk of infections in diabetics, can, in elderly diabetics, lead to serious and life-threatening infectious processes.
Because infection associated with aging can present in a subtle manner, prompt recognition of infection and treatment with appropriate empirical broad-spectrum antimicrobial agents in conjunction with surgical intervention may be needed to eradicate such infections.
Common sites of infection associated with diabetes mellitus include the respiratory tract, the gastrointestinal tract, the urinary tract, as well as the skin, soft tissue, and bony structures particularly of the feet.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
References
Rajagopalan, S. (2005). Serious infections in elderly patients with diabetes mellitus. Clinical Infectious Diseases, 40, 990–996.
Calvet, C.M., & Yoshikawa, T.T. (2001). Infections in diabetics. Infectious Disease Clinics of North America, 15, 407–421.
Harris, M.I., Hadden, W.C., Knowler, W.C., et al (1987). Prevalence of diabetes and impaired glucose tolerance and plasma glucose levels in US population aged 20–74 years. Diabetes, 36, 523–534.
Harris, M.I. (1990). Epidemiology of diabetes mellitus among the elderly. Clinics in Geriatric Medicine, 6, 703–719.
Gleckman, R.A., & Czachor, J.S. (1989). Managing diabetes-related infections in the elderly. Geriatrics, 44, 37–46.
Geerlings, S., & Hoepelman, A. (1999). Immune dysfunction in patients with diabetes mellitus (DM). FEMS Immunology & Medical Microbiology, 26, 259–265.
Terpenning, M.S., & Bradley, S.F. (1991). Why aging leads to increased susceptibility to infection. Geriatrics, 46, 77–80.
Fulop, T., Larbi, A., Westby, A., Mocchegiani, E., Hirokawa, K., & Pawles, G. (2005). Dysregulaton of T cell function in the elderly: scientific basis and clinical implications. Drugs Aging, 22, 589–603.
Leslie, C.A., Sapico, F.L., & Bessman, A.N. (1989). Infections in the diabetic host. Comprehensive Therapy, 15, 23–32.
Sapico, F.L., Leslie, C.A., & Bessman, A.N. (1991). Infections in the diabetic host. In R.B. Taylor (Ed.), Difficult Medical Managemen t (pp. 368–373). Philadelphia: W.B. Saunders.
Pawlec, G. (1999). Immunosenescence: impact in the young as well as the old?. Mechanisms of Aging & Development, 108, 1–7.
Miller, R.A. (1989). The cell biology of aging: immunological models. Journal of Gerontology, 44, B4–B8.
Abraham, G.N., Davis, D.M., Bennett, M.B., et al (1996). Immune system, functions and changes associated with aging. TASK Force on Immunology and Aging. National Institutes on Aging and Allergy and Infectious Diseases (pp. 9–15). Bethesda, MD: U.S. Dept of Health and Human Services, National Institute of Health.
Orme, T. (1995). Mechanisms underlying the increased susceptibility of aged mice to tuberculosis. Nutrition Review, 53(54), S35–S40.
Saltzman, R.L., & Peterson, P.K. (1987). Immunodeficiency of the elderly. Review of Infectious Diseases, 9, 1127–1139.
Phair, J.P., Kauffman, C.A., Bjornson, A., Gallagher, J., Adams, L., & Hess, E.V. (1978). Host defenses in the aged: evaluation of components of the inflammatory and immune responses. Journal of Infectious Diseases, 138, 67–73.
Ruben, F.L., & Uhrin, M. (1985). Specific immunoglobulin-class antibody responses in the elderly before and after 14-valent pneumococcal vaccine. Journal of Infectious Diseases, 151, 845–849.
Murasko, D.M., Bernstein, E.D., Gardner, E.M., et al (2002). Role of the humoral and cell-mediated immunity in protection from influenza disease after immunization of healthy elderly. Experimental Gerontology, 37, 427–439.
Gallacher, S., Thomson, G., Fraser, W.D., Fisher, B.M., Gemmell, C.G., & MacCuish, A.C. (1995). Neutrophil bactericidal function in diabetes mellitus: evidence for association with blood glucose control. Diabetes Medicine, 12, 916–920.
Delamaire, M., Maugendre, D., Moreno, M., Le Goff, M.C., Allannic, H., & Genetet, B. (1997). Impaired leukocyte function in diabetic patients. Diabetes Medicine, 14, 29–34.
Aleksandrovski, Y.A. (1998). Molecular mechanisms of diabetic complications. Biochemistry (Mosc), 63, 1249–1257.
Deresinski, S. (1995). Infections in the diabetic patient: strategies for the clinician. Current Infectious Disease Reports, 1, 1–12.
Leher, R.I., Howard, D.H., Sypherd, P.S., et al. (1980). Mucormycosis. Annals of Internal Medicine, 93–108.
Saltoglu, N., Tasova, Y., Zorludemir, S., & Dundar, I.H. (1998). Rhinocerebral zygomycosis treated with liposomal amphotericin B and surgery. Mycoses, 41, 45–49.
Idle, L., Buysshaert, I., De Man, R., Verlinde, A., De Laere, E., & Surmont, I. (2004). Zygomycosis in neutropenic patients with past Aspergillus infection: a role for pozaconazole?. Clinical Microbiology & Infection, 10, 862–863.
Greenberg, R.N., Mullane, K., Van Burik, J.A.H., et al (2006). Posaconazole as salvage therapy for zygomycosis. Antimicrobial Agents Chemotherapy, 50, 26–33.
Raad, I.I., Graybill, J.R., Bustamante, A.B., et al (2006). Safety of long-term oral posaconazole use in the treatment of refractory invasive fungal infections. Clinical Infectious Diseases, 42, 1726–1734.
Peterson, K.L., Wang, M., Canalis, R.F., et al (1997). Rhinocerebral mucormycosis: evolution of the disease and treatment options. Laryngoscope, 107, 855.
Schmidt, J., & Poublon, R. (1998). Rhinocerebral mycosis in immunocompromised patients: a case report and review of the literature. Rhinology, 36, 90.
Fairley, C., Sullivan, T.J., Bartley, P., et al (2000). Survival after rhino-orbital-cerebral mucormycosis in an immunocompetent patient. Ophthalmology 2000, 107, 555.
Rubin, J., & Yu, V.L. (1988). Malignant external otitis: insights into pathogenesis, clinical manifestations, diagnosis and therapy. American Journal of Medicine, 85, 391.
Gleckman, R., & Al-Wawi, M. (1999). A review of selective infections in the adult diabetic. Comprehensive Therapy 1999, 25, 109.
Sade, J., Lang, R., Gosken, S., et al (1989). Ciprofloxacin treatment of malignant external otitis. American Journal of Medicine, 87 (Suppl. 5A), 1385.
Mentzer, R.M., Jr., Golden, G.T., Chandler, J.G., et al (1975). A comparative appraisal of emphysematous cholecystitis. American Journal of Surgery, 129, 10–15.
Hutchinson, F.N., & Kaysen, G.A. (1988). Perinephric abscess: the missed diagnosis. Medical Clinics of North America, 72, 993–1014.
O’Connor, L.A., & De Guzman, J. (2001). Emphysematous cystitis: a radiographic diagnosis. American Journal of Emergency Medicine, 19, 211–213.
Jeng-Jong, H., & Chin-Chung, T. (2000). Emphysematous pyelonephritis: clinicoradiological classification, management, prognosis, and pathogenesis. Archives of Internal Medicine, 160, 797–805.
Whitehouse, F.W., & Root, H.F. (1956). Necrotizing renal papillitis and diabetes mellitus. Journal of the American Medical Association, 162, 444–447.
Pappas, P.G. (2006). Invasive candidiasis. Infectious Disease Clinics of North America, 20, 485–506.
Peleg, A.Y., Weerarathna, T., McCarthy, J.S., & Davis, T.M.E. (2007). Common infections in diabetes: pathogenesis, management and relationship to glycaemic control. Diabetes/Metabolism Research Review, 23, 1–3.
Sapico, F.L., Witte, J.L., Canawati, H.N., et al (1984). The infected foot of the diabetic patients: quantitative microbiology and analysis of clinical features. Review Infectious Diseases, 6 (Suppl.), S171–S176.
Suggested Reading
Calvet, C.M., & Yoshikawa, T.T. (2001). Infections in diabetics. Infectious Disease Clinics of North America, 15, 407–421.
Peleg, A.Y., Weerarathna, T., McCarthy, J.S., & Davis, T.M.E. (2007). Common infections in diabetes: pathogenesis, management and relationship to glycaemic control. Diabetes/ Metabolism Research Review, 23, 1–3.
Rajagopalan, S. (2005). Serious infections in elderly patients with diabetes mellitus. Clinical Infectious Diseases, 40, 990–996.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2009 Humana Press, a part of Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Rajagopalan, S. (2009). Infections in Diabetics. In: Norman, D., Yoshikawa, T. (eds) Infectious Disease in the Aging. Infectious Disease. Humana Press. https://doi.org/10.1007/978-1-60327-534-7_26
Download citation
DOI: https://doi.org/10.1007/978-1-60327-534-7_26
Published:
Publisher Name: Humana Press
Print ISBN: 978-1-60327-533-0
Online ISBN: 978-1-60327-534-7
eBook Packages: MedicineMedicine (R0)